| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |